Hvorfor faller dødeligheten av hjerte- Og karsykdommer?

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 16, 2000, Pages 1903-1905

  Mähönen, Markku ^a   Thelle, Dag S ^b  

^a Kirkenes Sykehus   (Norway)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; HEALTH; HEALTH BEHAVIOR; HUMAN; LIFESTYLE; MORTALITY; RISK FACTOR;

CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC STUDIES; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MORTALITY; RISK FACTORS; WORLD HEALTH;

EID: 0034690886     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Chambless L, Keil U, Dobson A, Mähönen M, Kuulasmaa K, Rajakangas A-M et al for the WHO MONICA Project. Population versus clinical view of case fatality from acute coronary disease. Results from WHO MONICA Project 1985-1990. Circulation 1997; 96: 3849-59.
2. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P for the WHO MONICA Project. Contribution of trends in survival and coronary event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 1999; 353: 1547-58.
3. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H et al for the WHO MONICA Project. Estimating the contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000; 355: 675-87.
4. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mähönen M, Cepatitis Z, Kuulasmaa K et al for the WHO MONICA Project. Estimating the contribution of changes in coronary care to improving survival, event rates and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000; 355: 688-700.
5. www.ktl.fi/publications/monica/manual/ index.htm.
6. www.ktl.fi/publications/monica.
7. Reikvam Å. Forbedret behandling av hjerteinfarkt - hvordan har sykehusdødeligheten utviklet seg? Tidsskr Nor Lægeforen 1999; 119: 1078-9.
8. Wood AJJ. Adjunctive therapy of acute myocardial infarction - evidence from clinical trials. N Engl J Med 1996; 335: 1660-7.
9. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
10. The Norwegian multicenter study group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304: 801-17.
11. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
12. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW et al. Effect of coronary artery bypass graft surgery on survival: overwiev of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563-70.
13. Salomaa V, Miettinen H, Kuulasmaa K, Niemelä M, Ketonen M, Vuorenmaa T et al. Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. Circulation 1996; 94: 3130-7.
14. Hunink MGM, Goldman L, Tosteson ANA, Mittleman MA, Goldman PA, Williams LW et al. The recent decline in mortality from coronary heart disease, 1980-1990. JAMA 1997; 277: 535-42.
15. Salomaa V, Rosamond W, Mähörien M. Decreasing mortality from acute myocardial infarction: effect of incidence and prognosis. J Cardiovasc Risk 1999; 6: 69-75.
16. Mähönen M, Salomaa V, Torppa J, Miettinen H, Pyörälä K, Immonen-Räihä P et al. The validity of routine mortality statistics on coronary heart disease in Finland. J Clin Epidemiol 1999; 52: 157-66.
17. Juel K, Sjøl A. Decline in mortality from heart disease in Denmark: some methodological problems. J Clin Epidemiol 1995; 48: 467-72.
18. Murray CJL, Lopez AD. The global burden of disease. Bd. 1. Harvard: Harvard University Press, 1996: 132.
19. Håheim LL. Validering av dødsårsaker etter alder. Tidsskr Nor Lægeforen 1999; 119: 826-30.
20. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischemic heart disease in Finland. BMJ 1994; 309: 23-7.
21. Vartiainen E, Pekkanen J, Koskinsn S, Jousilahti P, Salomaa V, Puska P. Do changes in cardiovascular risk factors explain the increasing socioeconomic difference in mortality from ischemic heart disease in Finland? J Epidemiol Community Health 1998; 52: 416-9.
22. Sans S, Kesteloot H, Kromhout D on behalf of the Task Force. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on cardiovascular mortality and morbidity statistics in Europe. Eur Heart J 1997; 18: 1231-48.